Last reviewed · How we verify
IDP-126 Component B — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
IDP-126 Component B (IDP-126 Component B) — Bausch Health Americas, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IDP-126 Component B TARGET | IDP-126 Component B | Bausch Health Americas, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IDP-126 Component B CI watch — RSS
- IDP-126 Component B CI watch — Atom
- IDP-126 Component B CI watch — JSON
- IDP-126 Component B alone — RSS
Cite this brief
Drug Landscape (2026). IDP-126 Component B — Competitive Intelligence Brief. https://druglandscape.com/ci/idp-126-component-b. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab